Table 3.
Availability of screening/treatment protocols and referral guidelines for antenatal and neonatal interventions
| Number of facilities | |||
|---|---|---|---|
| Management Protocol/Guideline | Available, displayed | Available, not displayed | None available |
| Screening and treatment guidelines/cards (N = 15) | |||
| Syphilis screening guidelinesa | 0 | 0 | 13 |
| HIV screening guidelines | 8 | 3 | 4 |
| Malaria IPT administration guidelines | 11 | 1 | 3 |
| Tetanus toxoid administration guidelines | 13 | 1 | 1 |
| STI partner notification cards (HIV & syphilis) | 0 | 0 | 15 |
| Syphilis treatment protocols/cards (N = 13)a | |||
| Treatment protocol for seropositive mothers | 1 | 1 | 11 |
| Treatment protocol for babies of seropositive mothers | 1 | 0 | 12 |
| HIV treatment protocols and referral guidelines | |||
| Treatment protocol for seropositive mothers (n = 8)b | 8 | 0 | 0 |
| Treatment protocol for babies of seropositive mothers (n = 8)b | 7 | 1 | 0 |
| Referral guidelines for treatment of seropositive mothers (n = 7)c | 0 | 0 | 7 |
| Referral guidelines for treatment of babies of seropositive mothers (n = 7)c | 0 | 0 | 7 |
STI, sexually transmitted infection; a2 facilities that had not started screening pregnant women for syphilis were excluded; b7 facilities that were not offering antiretroviral treatment for HIV were excluded; c8 facilities that were offering antiretroviral treatment for HIV were excluded